Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Weight Loss Drugs Market from 2024 to 2033?
The weight loss drugs market has experienced exponential growth in recent years. It will rise from $1.94 billion in 2023 to $2.87 billion in 2024, with a CAGR of 47.8%. The growth is attributed to increasing obesity rates, lifestyle changes, greater awareness, early diagnosis of medical conditions, and rising healthcare expenditures.
The weight loss drugs market is expected to experience exponential growth, reaching $12.17 billion by 2028, with a CAGR of 43.5%. The growth is driven by the increasing geriatric population, social media influence, trends in fitness and wellness, cultural perceptions of beauty, and investments by the pharmaceutical industry. Key trends include advancements in technology, a focus on non-prescription solutions, personalized medicine, combination therapies, and post-market surveillance.
Claim Your Free Sample of the Global Weight Loss Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13761&type=smp
What Key Factors Are Fueling the Growth of the Weight Loss Drugs Market?
Increasing obesity rates are expected to drive the weight loss drugs market. Obesity, defined by a body mass index (BMI) of 30 or more, is a major public health concern. Weight loss drugs support individuals in achieving weight loss by controlling appetite or affecting nutrient absorption. According to the CDC, a US-based organization, 19 states exceeded a 35% obesity rate in 2021, reaching 22 states in 2022, while the World Obesity Federation, a UK-based organization, predicts that by 2035, over 4 billion people globally will be obese. Thus, rising obesity rates drive the weight loss drugs market.
What Are the Major Segments of the Weight Loss Drugs Market?
1) By Type: Liquid, Tablets, Capsules
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters
What New Trends Are Transforming the Weight Loss Drugs Market?
Companies in the weight loss drug market are developing innovative products like Zepbound (tirzepatide) injection to better serve patients. Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, available as a once-weekly injectable treatment for chronic weight management. In November 2023, Eli Lilly and Company, a US-based pharmaceutical company, received FDA approval for tirzepatide injection (Zepbound) for chronic weight management in adults with overweight or obesity and at least one weight-related condition. Zepbound is the first FDA-approved obesity treatment to activate both GIP and GLP-1 receptors, positioning it for commercial success.
Order Now for Fast Delivery of Your Weight Loss Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
Which Regions Are Driving Growth in the Weight Loss Drugs Market?
North America was the largest region in the Weight Loss Drugs market in 2023. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Weight Loss Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the weight loss drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Weight Loss Drugs Market Include
1. Weight Loss Drugs Market Executive Summary
2. Weight Loss Drugs Market Segments
3. Weight Loss Drugs Market Size And Template Market Growth Rate
4. Key Weight Loss Drugs Market Trends
5. Major Weight Loss Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Weight Loss Drugs Market
26. Top Weight Loss Drugs Companies
27. Weight Loss Drugs Market Opportunities And Strategies
28. Weight Loss Drugs Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Narcotic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report
Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024
Antiparasitic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
